About our work regulating GMOs
Find out how we support the Gene Technology Regulator to manage, and protect against, risks posed by GMOs.
Approved GMOs in Australia
Details about approved applications, dealings and licences, accredited organisations, and active crop field trial sites.
Application and reporting forms
Access forms for licence applications, organisation accreditation, and reporting obligations.
For Institutional Biosafety Committees
Useful resources for IBCs covering records of assessment, classification of NLRDs and contained dealings.
Licence consultation closed (DIR 185)
The consultation period for a clinical trial with a genetically modified Bordetella pertussis for the prevention of whooping cough from Novotech (Australia) Pty Ltd has now closed.
Licence consultation open (DIR 187)
The consultation period for a clinical trial with a genetically modified alphavirus for treatment of cancer from VRT Pharmaceuticals Pty Ltd is now open.
Licence consultation open (DIR 186)
The consultation period for a field trial of genetically modified wheat and barley with enhanced yield and improved abiotic stress tolerance from The University of Adelaide is now open.
Subscribe to updates about the regulation of gene technology
Get notified about applications to release a GMO into the environment, when an application is open for comment and when changes are made to Australia's gene technology legislation.
Apply to work with GMOs
Authorisations to deal with GMOs
See more about the types of approvals for GMO dealings and how to apply.
Certify your facilities
Find out more about the certification process including the requirements for each type of facility, and how to apply.
Get your organisation accredited
All organisations dealing with GMOs should consider accreditation. Find out more including how to apply.
Transport, storage and disposal
Learn about importing, transporting, storing and disposing of GMOs or products containing GMOs.
Advice on how organisations can continue to comply with certification guidelines and licence conditions when key staff are not on-site and common laboratory consumables are in limited supply.
The report describes the roles and responsibilities of the Gene Technology Regulator (the Regulator) and the Office of the Gene Technology Regulator (OGTR) during 2020-21.